MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Alpha-synuclein enhances histone H3 lysine-9 dimethylation

N. Sugeno, S. Jäckel, A. Voigt, T. Hasegawa, P. Kahle (Tübingen, Germany)

Meeting: 2017 International Congress

Abstract Number: 534

Keywords: Alpha-synuclein, Synucleinopathies

Session Information

Date: Tuesday, June 6, 2017

Session Title: Parkinson's Disease: Pathophysiology

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To explore the nuclear function of alpha-synuclein (αS).

Background: αS is a protein linked to Parkinson’s disease (PD) and related neurodegenerative disorders. It is mostly localized within synapses, but αS has also been suggested to play a role in the nucleus. The aim of this study is to explore epigenetic events through αS. 

Methods: Histone proteins, extracted from αS transgenic Drosophila and αS inducible SH-SY5Y neuroblastoma cells, were separated by SDS-PAGE, then histone marks were analyzed by western blotting. To determine the level of histone lysine methyltransferase (HMT) and histone lysine demethylase (KDM), mRNA levels were measured by RT-PCR. Chromatin immunoprecipitation was performed by standard protocol using H3K9me2 and REST antibodies. Target genes were amplified by specific primer pairs.

Results: Overexpression of αS in male flies as well as in retinoic acid pre-treated neuroblastoma cells led to an elevation of histone H3K9 methylation, mostly mono- (H3K9me1) and di- (H3K9me2), which mean transcriptional repression. The transient increase of H3K9 methylation in SY5Y cells was slightly preceded by an induction of the euchromatic histone lysine N-methyltransferase 2 (EHMT2). Pharmacological inhibition of EHMT2 reduced the H3K9 methylations. EHMT2 and H3K9me2 can function within the REST complex. H3K9me2 chromatin immunoprecipitation (ChIP) survey of REST regulated genes showed significantly increased promoter occupancy of the synaptosomal-associated protein SNAP25 and cell adhesion molecule L1CAM genes after αS induction. Transcripts and protein levels of SNAP25 were also decreased.

Conclusions: αS overexpression enhances the histone modifications H3K9me1 and H3K9me2, likely involving EHMT2 known to catalyze these histone modifications. While, H3K9me2 strongly appears at the SNAP25 promoter, possibly affecting SNARE complex assembly and hence synaptic function regulated by αS.

References: Sugeno N, Jackel S, Voigt A, Wassouf Z, Schulze-Hentrich J, Kahle PJ (2016) alpha-Synuclein enhances histone H3 lysine-9 dimethylation and H3K9me2-dependent transcriptional responses. Scientific reports 6: 36328

To cite this abstract in AMA style:

N. Sugeno, S. Jäckel, A. Voigt, T. Hasegawa, P. Kahle. Alpha-synuclein enhances histone H3 lysine-9 dimethylation [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/alpha-synuclein-enhances-histone-h3-lysine-9-dimethylation/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/alpha-synuclein-enhances-histone-h3-lysine-9-dimethylation/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley